Page last updated: 2024-10-16

carbamates and Elevated Cholesterol

carbamates has been researched along with Elevated Cholesterol in 5 studies

Research Excerpts

ExcerptRelevanceReference
" Adverse events (AEs) associated with the study medication occurred in 21% of patients."2.74Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program. ( Luque, I; Mallolas, J; Pérez-Elias, MJ; Rodríguez-Alcántara, F; Sánchez-Conde, M; Soriano, V, 2009)
" Adverse events (clinical events and absolute neutrophil counts, total cholesterol and triglycerides, and alanine transaminase) were summarised and DAIDS gradings characterised severity."1.40Post-licensing safety of fosamprenavir in HIV-infected children in Europe. ( Duong, T; Ene, L; Galli, L; Giaquinto, C; Goetghebuer, T; Judd, A; Noguera Julian, A; Pimenta, JM; Ramos Amador, JT; Thorne, C, 2014)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Judd, A1
Duong, T1
Galli, L1
Goetghebuer, T1
Ene, L1
Noguera Julian, A1
Ramos Amador, JT1
Pimenta, JM1
Thorne, C1
Giaquinto, C1
Pérez-Elias, MJ1
Sánchez-Conde, M1
Soriano, V1
Mallolas, J1
Luque, I1
Rodríguez-Alcántara, F1
Bochkov, VN1
Kuz'menko, ES1
Rezink, T1
Tkachuk, VA1
Sliskovic, DR1
Krause, BR1
Picard, JA1
Anderson, M1
Bousley, RF1
Hamelehle, KL1
Homan, R1
Julian, TN1
Rashidbaigi, ZA1
Stanfield, RL1

Trials

1 trial available for carbamates and Elevated Cholesterol

ArticleYear
Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program.
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:1

    Topics: Adult; Carbamates; CD4 Lymphocyte Count; Comorbidity; Drug Therapy, Combination; Female; Fever; Fura

2009

Other Studies

4 other studies available for carbamates and Elevated Cholesterol

ArticleYear
Post-licensing safety of fosamprenavir in HIV-infected children in Europe.
    Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:3

    Topics: Adolescent; Anti-HIV Agents; Carbamates; Child; Cohort Studies; Europe; Female; Follow-Up Studies; F

2014
["Classical" apo B,E-receptor does not mediate the activating effect of low density lipoproteins on the second messenger system in human platelets and vascular smooth muscle cells].
    Biokhimiia (Moscow, Russia), 1994, Volume: 59, Issue:9

    Topics: Acetylation; Arginine; Blood Platelets; Carbamates; Cells, Cultured; Heparin; Humans; Hypercholester

1994
Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 6. The first water-soluble ACAT inhibitor with lipid-regulating activity.
    Journal of medicinal chemistry, 1994, Mar-04, Volume: 37, Issue:5

    Topics: Absorption; Animals; Anticholesteremic Agents; Biological Availability; Carbamates; Cholesterol; Cho

1994
Metabolic profile of protease inhibitors studied.
    AIDS patient care and STDs, 1999, Volume: 13, Issue:9

    Topics: Adipose Tissue; Animals; Carbamates; Disease Models, Animal; Furans; HIV Protease Inhibitors; Humans

1999